Featured Research

from universities, journals, and other organizations

Hyperbaric oxygen could provide relief of chronic pain

Date:
April 22, 2012
Source:
Federation of American Societies for Experimental Biology (FASEB)
Summary:
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management. One possible solution is hyperbaric oxygen (HBO2) therapy.

Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.

Related Articles


One possible solution is hyperbaric oxygen (HBO2) therapy, which is the clinical application of pure oxygen at higher-than-atmospheric pressure for limited time periods to achieve beneficial results. The FDA has approved HBO2 treatment for certain conditions such as decompression sickness (the 'bends') and carbon monoxide poisoning but not for pain specifically.

Yangmiao Zhang, a graduate student in the laboratory of Raymond M. Quock, Ph.D., Professor of Pharmaceutical Sciences at Washington State University, evaluated whether relief of neuropathic pain could be enhanced by increasing the number of HBO2 treatments. Male rats were injected and tested on their paws for pain thresholds at four different times. Twenty-four hours after the last injection, rats were treated with a 60-minute period of room air (the control), or HBO2. Rats that underwent the most number of HBO2 treatments (four 60-minute treatments) recovered approximately 7 days earlier than rats who received a single treatment.

Quock concluded, "While most other HBO2 pain studies focus on inflammatory mechanisms, we believe that HBO2 also reduces pain by acting in the brain. Studying the mechanism of how HBO2 can reduce neuropathic pain can reveal molecular targets in the brain and possibly stimulate the development of new drugs that act on the same targets for long-term relief of chronic pain." This research was supported by Washington State University.


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology (FASEB). Note: Materials may be edited for content and length.


Cite This Page:

Federation of American Societies for Experimental Biology (FASEB). "Hyperbaric oxygen could provide relief of chronic pain." ScienceDaily. ScienceDaily, 22 April 2012. <www.sciencedaily.com/releases/2012/04/120422162210.htm>.
Federation of American Societies for Experimental Biology (FASEB). (2012, April 22). Hyperbaric oxygen could provide relief of chronic pain. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2012/04/120422162210.htm
Federation of American Societies for Experimental Biology (FASEB). "Hyperbaric oxygen could provide relief of chronic pain." ScienceDaily. www.sciencedaily.com/releases/2012/04/120422162210.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins